Filter
2123
Filtered Results: 2123
Text search:
pharmaceutical
needs
Featured
Recommendations
186
New Publications
554
Language
Document type
No document type
1080
Studies & Reports
431
Guidelines
306
Manuals
101
Strategic & Response Plan
91
Fact sheets
47
Training Material
29
Situation Updates
16
Resource Platforms
8
Infographics
7
Brochures
5
Online Courses
2
Countries / Regions
India
86
Global
84
Kenya
81
Ethiopia
78
South Africa
55
Western and Central Europe
47
Nigeria
45
Uganda
41
Sierra Leone
39
Liberia
39
Ghana
30
Namibia
30
Rwanda
29
Africa
29
Tanzania
29
Nepal
28
Malawi
27
Zambia
27
Bangladesh
25
Ukraine
24
Philippines
20
Syria
19
Zimbabwe
19
Latin America and the Carribbean
19
Eastern Europe
19
Cambodia
18
Lesotho
17
South–East Asia Region
15
Indonesia
14
West and Central Africa
12
Botswana
12
Congo, Democratic Republic of
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
Germany
9
Eastern Europe and Central Asia
9
East and Southern Africa
9
South Sudan
9
Cameroon
8
Asia
8
Venezuela
8
Thailand
6
Senegal
6
Burkina Faso
6
Guinea
6
Haiti
6
Middle East and North Africa
6
Albania
5
Mozambique
5
Western Pacific Region
5
Russia
5
Pakistan
5
China
4
Laos
4
Vietnam
4
Papua New Guinea
4
North Macedonia
3
Benin
3
Fiji
3
Afghanistan
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Lebanon
3
Brazil
3
Egypt
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Chile
2
Kyrgyzstan
2
Peru
2
Lithuania
2
Jamaica
2
Moldova
2
Yemen
2
Georgia
2
Central African Republic
2
Iraq
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Kazakhstan
1
Iran
1
Canada
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Southern Africa
1
Sri Lanka
1
Romania
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
845
Clinical Guidelines
139
Public Health
110
Key Resources
100
Women & Child Health
51
Pharmacy & Technologies
32
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
205
Pharmacy
188
COVID-19
174
Mental Health
122
HIV
114
TB
94
NTDs
70
Rapid Response
60
Planetary Health
54
NCDs
49
Caregiver
42
Global Health Education
39
Health Financing Toolbox
38
Ebola & Marburg
36
Conflict
36
Refugee
16
Disability
16
Specific Hazards
14
Polio
11
Natural Hazards
9
Cholera
4
Social Ethics
4
Zika
3
South Sudan
1
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
The “United Nations Framework for the immediate socio-economic response to COVID-19: Shared responsibility, global solidarity and urgent action for people in need” calls for protecting jobs, businesses and livelihoods to set in motion a safe recovery of societies and economies as soon as possibl...
This report tells the stories of some of the world’s 7.1 million refugee children of school age under UNHCR’s mandate. In addition, it looks at the educational aspirations of refugee youth eager to continue learning after secondary education, and highlights the need for strong partnerships in o...
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic...
The procurement of essential medicines and other health products is a critical function in support of the effective discharge of WHO’s mandate, and WHO values the importance of the quality of essential medicines and health products that are supplied to countries. The first World Health Assembly in...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for trea...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Specifically the Strategy focuses on five strategic objectives:
commitment to action on Healthy Ageing in every country;
developing age-friendly environments;
aligning health systems to the needs of older populations;
developing sustainable and equitable systems for providing lon...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
The following checklist can help hospitals assess and improve their preparedness for responding to a community-wide outbreak of COVID-19. Each hospital will need to adapt this checklist to meet its unique needs and circumstances. This checklist should be used as one of several tools for evaluating c...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
The National Asthma Education Programme (NAEP) is a registered non-profit organisation whose mission is to provide asthma education to healthcare professionals, patients and the lay public. It was founded in 1994 by Dr Mike Greenblatt and Profs Dave Luyt and Robin Green. This year NAEP celebrates it...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
